1. Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report. Issue 1 (December 2016) Authors: Ikeda, Satoshi; Sekine, Akimasa; Baba, Tomohisa; Yamakawa, Hideaki; Morita, Masato; Kitamura, Hideya; Ogura, Takashi Journal: BMC pulmonary medicine Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An exploratory trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis: a preliminary multicenter report. (19th March 2015) Authors: Enomoto, Noriyuki; Chida, Kingo; Suda, Takafumi; Kaida, Yusuke; Taniguchi, Masami; Azuma, Arata; Hayashi, Hiroki; Ogura, Takashi; Kitamura, Hideya; Yamaguchi, Ou; Ando, Masayuki; Sato, Atsuhiko; Kudo, Shoji Journal: Clinical respiratory journal Issue: Volume 10:Number 6(2016) Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. Issue 9 (September 2019) Authors: Maher, Toby M; Stowasser, Susanne; Nishioka, Yasuhiko; White, Eric S; Cottin, Vincent; Noth, Imre; Selman, Moisés; Rohr, Klaus B; Michael, Andreas; Ittrich, Carina; Diefenbach, Claudia; Jenkins, R Gisli; Corte, Tamera; Glaspole, Ian; Holmes, Mark; Troy, Lauren; Veitch, Elizabeth; Bondue, Benjamin... Journal: Lancet Issue: Volume 7:Issue 9(2019) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical characteristics of Japanese patients with moderate to severe COVID-19. Issue 6 (June 2021) Authors: Otoshi, Ryota; Hagiwara, Eri; Kitayama, Takaaki; Yamaya, Takafumi; Higa, Katsuyuki; Murohashi, Kota; Sato, Yozo; Tabata, Erina; Shintani, Ryota; Okabayashi, Hiroko; Ikeda, Satoshi; Niwa, Takashi; Nakazawa, Atsuhito; Oda, Tsuneyuki; Okuda, Ryo; Sekine, Akiamasa; Kitamura, Hideya; Baba, Tomohisa; K... Journal: Journal of infection and chemotherapy Issue: Volume 27:Issue 6(2021) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical features of usual interstitial pneumonia with anti‐neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Issue 5 (19th March 2016) Authors: Hosoda, Chiaki; Baba, Tomohisa; Hagiwara, Eri; Ito, Hiroyuki; Matsuo, Norikazu; Kitamura, Hideya; Iwasawa, Tae; Okudela, Koji; Takemura, Tamiko; Ogura, Takashi Journal: Respirology Issue: Volume 21:Issue 5(2016) Page Start: 920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Diagnostic significance of secondary bacteremia in patients with COVID-19. Issue 4 (April 2023) Authors: Nakagawara, Kensuke; Kamata, Hirofumi; Chubachi, Shotaro; Namkoong, Ho; Tanaka, Hiromu; Lee, Ho; Otake, Shiro; Fukushima, Takahiro; Kusumoto, Tatsuya; Morita, Atsuho; Azekawa, Shuhei; Watase, Mayuko; Asakura, Takanori; Masaki, Katsunori; Ishii, Makoto; Endo, Akifumi; Koike, Ryuji; Ishikura, Hiroy... Journal: Journal of infection and chemotherapy Issue: Volume 29:Issue 4(2023) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy. Issue 17 (15th July 2022) Authors: Sekine, Akimasa; Matama, Goushi; Hagiwara, Eri; Tabata, Erina; Ikeda, Satoshi; Oda, Tsuneyuki; Okuda, Ryo; Kitamura, Hideya; Baba, Tomohisa; Satoh, Hiroaki; Misumi, Toshihiro; Komatsu, Shigeru; Iwasawa, Tae; Ogura, Takashi Journal: Thoracic cancer Issue: Volume 13:Issue 17(2022) Page Start: 2443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial. (October 2021) Authors: Inoue, Yoshikazu; Suda, Takafumi; Kitamura, Hideya; Okamoto, Masaki; Azuma, Arata; Inase, Naohiko; Kuwana, Masataka; Makino, Shigeki; Nishioka, Yasuhiko; Ogura, Takashi; Takizawa, Ayako; Ugai, Hiroyuki; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Takeuchi, Tsutomu Journal: Respiratory medicine Issue: Volume 187(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inhalation challenge test using pigeon eggs for chronic hypersensitivity pneumonitis. Issue 12 (18th October 2020) Authors: Okuda, Ryo; Takemura, Tamiko; Mikami, Yu; Hagiwara, Eri; Iwasawa, Tae; Baba, Tomohisa; Kitamura, Hideya; Komatsu, Shigeru; Okudela, Koji; Ohashi, Kenichi; Ogura, Takashi Journal: Clinical & experimental allergy Issue: Volume 50:Issue 12(2020) Page Start: 1381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. Issue 1 (December 2016) Authors: Sasano, Hajime; Hagiwara, Eri; Kitamura, Hideya; Enomoto, Yasunori; Matsuo, Norikazu; Baba, Tomohisa; Iso, Shinichiro; Okudela, Koji; Iwasawa, Tae; Sato, Shinji; Suzuki, Yasuo; Takemura, Tamiko; Ogura, Takashi Journal: BMC pulmonary medicine Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗